Corbus Pharmaceuticals Holdings Inc (CRBP)
17.82
-0.16
(-0.89%)
USD |
NASDAQ |
Nov 27, 16:00
17.82
0.00 (0.00%)
After-Hours: 17:44
Corbus Pharmaceuticals Holdings Enterprise Value: 59.63M for Nov. 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 26, 2024 | 59.63M |
| November 25, 2024 | 59.26M |
| November 22, 2024 | 53.41M |
| November 21, 2024 | 44.40M |
| November 20, 2024 | 36.48M |
| November 19, 2024 | 42.33M |
| November 18, 2024 | 44.77M |
| November 15, 2024 | 42.94M |
| November 14, 2024 | 54.39M |
| November 13, 2024 | 61.94M |
| November 12, 2024 | 59.14M |
| November 11, 2024 | 67.05M |
| November 08, 2024 | 69.37M |
| November 07, 2024 | 66.20M |
| November 06, 2024 | 70.95M |
| November 05, 2024 | 73.88M |
| November 04, 2024 | 63.64M |
| November 01, 2024 | 46.72M |
| October 31, 2024 | 35.02M |
| October 30, 2024 | 42.45M |
| October 29, 2024 | 37.95M |
| October 28, 2024 | 39.65M |
| October 25, 2024 | 39.29M |
| October 24, 2024 | 42.94M |
| October 23, 2024 | 42.70M |
| Date | Value |
|---|---|
| October 22, 2024 | 53.29M |
| October 21, 2024 | 55.85M |
| October 18, 2024 | 64.86M |
| October 17, 2024 | 67.54M |
| October 16, 2024 | 73.63M |
| October 15, 2024 | 70.47M |
| October 14, 2024 | 68.27M |
| October 11, 2024 | 69.37M |
| October 10, 2024 | 63.77M |
| October 09, 2024 | 66.20M |
| October 08, 2024 | 79.11M |
| October 07, 2024 | 71.93M |
| October 04, 2024 | 74.61M |
| October 03, 2024 | 83.13M |
| October 02, 2024 | 85.57M |
| October 01, 2024 | 74.85M |
| September 30, 2024 | 91.90M |
| September 27, 2024 | 115.75M |
| September 26, 2024 | 122.62M |
| September 25, 2024 | 120.93M |
| September 24, 2024 | 84.68M |
| September 23, 2024 | 92.51M |
| September 20, 2024 | 98.77M |
| September 19, 2024 | 486.47M |
| September 18, 2024 | 457.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-40.47M
Minimum
May 12 2022
703.09M
Maximum
Sep 02 2020
137.54M
Average
43.18M
Median
Nov 02 2021
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 9.864M |
| Perspective Therapeutics Inc | 31.23M |
| Protalix BioTherapeutics Inc | 96.30M |
| Electromed Inc | 244.02M |
| Armata Pharmaceuticals Inc | 175.29M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.78M |
| Total Expenses (Quarterly) | 15.50M |
| EPS Diluted (Quarterly) | -1.15 |
| Earnings Yield | -26.21% |
| Normalized Earnings Yield | -68.65 |